Immunologic and Survival Benefits of Combined Heart-liver Transplantation in Children
- PMID: 34416752
- PMCID: PMC8932196
- DOI: 10.1097/TP.0000000000003810
Immunologic and Survival Benefits of Combined Heart-liver Transplantation in Children
Conflict of interest statement
The authors declare no conflicts of interest.
References
-
- Cotter TG, Wang J, Peeraphatdit T, et al. Simultaneous heart-liver transplantation for congenital heart disease in the United States: rapidly increasing with acceptable outcomes. Hepatology. 2021;73:1464–1477. - PubMed
-
- Tabarsi N, Guan M, Simmonds J, et al. Meta-analysis of the effectiveness of heart transplantation in patients with a failing fontan. Am J Cardiol. 2017;119:1269–1274. - PubMed
-
- Reardon LC, DePasquale EC, Tarabay J, et al. Heart and heart-liver transplantation in adults with failing Fontan physiology. Clin Transplant. 2018;32:e13329. - PubMed
-
- Patel ND, Sullivan PM, Sabati A, et al. Routine surveillance catheterization is useful in guiding management of stable fontan patients. Pediatr Cardiol. 2020;41:624–631. - PubMed
-
- Webber S, Zeevi A, Mason K, et al.; CTOTC-04 Investigators. Pediatric heart transplantation across a positive crossmatch: first year results from the CTOTC-04 multi-institutional study. Am J Transplant. 2018;18:2148–2162. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
